Heart-Transplant Program Opens Access to Hep C-Positive Donors

"UW Medicine's heart-transplant team this month began giving all of its patients access to suitable donor hearts from decedents who tested positive for the hepatitis C virus (HCV). Previously, these organs were available only to patients who already had the virus. The team is taking this step because early results from a few U.S. transplant centers show that an eight- to 12-week course of medication can eradicate HCV from transplant patients postoperatively without imperiling the donor organ's viability or the patient's health."

Download Document

The browser you're using does not support embedded PDFs. Please click the button above to download a copy of this document.